Skip to content

Reference Values and Clinical Screening Test of Diffuse Noxious Inhibitory Controls (DNIC)

Unknown statusNCT03376867
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

Brief summary (from the registry)

Chronic pain (CP) is disabling for people triggering important costs for society. A deficit of diffuse noxious inhibitory controls (DNIC) is one of the CP mechanisms. DNICs are evaluated in research setting using a CPM protocol (conditioned pain modulation). There is a lack of reference values on the effectiveness of DNICs. Wider research on DNIC will help to understand CP and to develop a clinical screening test evaluating DNICs.

Study details

Official title
Reference Values of Diffuse Noxious Inhibitory Controls (DNIC) Intensity in a Healthy Adult Population and Develop a Clinical Test to Evaluate DNIC
Conditions
Interventions
  • Other: Conditioned pain modulation
Sponsor
Université de Sherbrooke
Collaborators
Canadian Institutes of Health Research (CIHR); Centre for Research of CHUS (CRCHUS); CIHR/SPOR - chronic pain network
Start date
2017-11-27
Primary completion
2022-02-28
Sex
All
Age range
from 18 Years to 79 Years
Healthy volunteers
true
Results posted
No results posted in this snapshot
Countries
Canada
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18-79 years old * Able to provide consent Exclusion Criteria: * cardiovascular disease (arrhythmia, cerebrovascular accident, infarction...) * Raynaud syndrome * severe psychiatric disease (dementia, schizophrenia, psychosis, major depression) * injuries or loss sensitivity to their forearms or hands * pregnant women or in post-partum period (\<1 year)

Canadian sites (1)

FacilityCityProvince
Universite de SherbrookeSherbrookeQuebec

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03376867